|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-GFPSpark tag||CG90273-ACG|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-OFPSpark / RFP tag||CG90273-ACR|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-Flag tag||CG90273-CF|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-His tag||CG90273-CH|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-Myc tag||CG90273-CM|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, C-HA tag||CG90273-CY|
|Cynomolgus monkey FAS Gene cDNA clone plasmid||CG90273-G|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, N-Flag tag||CG90273-NF|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, N-His tag||CG90273-NH|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, N-Myc tag||CG90273-NM|
|Cynomolgus monkey FAS ORF mammalian expression plasmid, N-HA tag||CG90273-NY|
|Cynomolgus monkey FAS natural ORF mammalian expression plasmid||CG90273-UT|
|Learn more about expression Vectors|
CD95 (APO-1/Fas) is an important inducer of the extrinsic apoptosis signaling pathway and therapy induced apoptosis of many tumor cells has been linked to the activity of CD95. is a prototype death receptor characterized by the presence of an 80 amino acid death domain in its cytoplasmic tail. This domain is essential for the recruitment of a number of signaling components upon activation by either agonistic anti-CD95 antibodies or cognate CD95 ligand that initiate apoptosis. The complex of proteins that forms upon triggering of CD95 is called the death-inducting signaling complex (DISC). The DISC consists of an adaptor protein and initiator caspases and is essential for induction of apoptosis. CD95 is also crucial for the negative selection of B cells within the germinal center (GC). Impairment of CD95-mediated apoptosis results in defective affinity maturation and the persistence of autoreactive B-cell clones. Changes in the expression of CD95 and/or its ligand CD95L are frequently found in human cancer. The downregulation or mutation of CD95 has been proposed as a mechanism by which cancer cells avoid destruction by the immune system through reduced apoptosis sensitivity. Thus, CD95 has therefore been viewed as a tumor suppressor. CD95 has been reported to be involved in the activation of NF-kappaB, MAPK3/ERK1, MAPK8/JNK, and the alternate pathways for CTL-mediated cytotoxicity. Accordingly, this protein is implicated in the pathogenesis of various malignancies and diseases of the immune system. The CD95/CD95L system was implicated in the etiology of inflammatory bowel disease (IBD) based, primarily, on the finding that CD95 is highly expressed in the intestinal epithelial cells and that epithelial apoptosis is increased in IBD.